Vicarious Surgical Inc.

Vicarious Surgical Inc. reported a net loss of $50.2 million for fiscal year 2025, driven by a loss from operations of $50.0 million. The company generated no revenue, with total operating expenses of $50.0 million primarily consisting of research and development ($33.6 million), general and administrative ($15.2 million), and sales and marketing ($2.2 million). Other expenses included a loss on disposal of leasehold improvements of $1.9 million and a change in fair value of warrant liabilities of $787K, partially offset by interest and other income of $973K. The company ended the year with $19.6 million in total assets, including $2.6 million in cash and cash equivalents and $7.2 million in short-term investments, against total liabilities of $9.7 million. Net cash used in operating activities was $45.1 million, while investing activities provided $32.1 million primarily from sales and maturities of investments, and financing activities provided $5.8 million from equity and debt issuances. The company's accumulated deficit increased to $246.1 million, reflecting ongoing investment in development activities.

Key Takeaways